08.26.26 -- Explore AI-Driven Data Insights And Tools Reshaping Research

AI is advancing the way clinical trial results are analyzed and interpreted. But those advancements still depend on the quality and reliability of the data generated during the trial itself.

Understanding the global clinical trial landscape is crucial in our interconnected world, as these trials are pivotal for advancing medical innovation. Explore strategies for navigating these global studies.

Discover how functional service providers (FSPs) are reshaping clinical research by offering specialized expertise, flexible resources, and cost-effective solutions.

See how experienced compounding support helps ensure study drugs are prepared accurately and consistently across administration routes, meeting cGMP requirements while supporting clinical protocols.

This clip outlines the key warning signs that an RTSM is no longer meeting study needs and offers practical guidance for recognizing risk early and making decisions that support trial continuity.

AI-enabled clinical trial technology enables faster processing of large data volumes, thereby enhancing workflows, easing the burden on busy trial teams, and protecting patients.

Central eSource improves trial outcomes and transforms the conduct of clinical trials by replacing disparate, site-specific source templates with a unified, sponsor-designed framework.

When asked what advice they have for sponsors, sites, or regulators, Natalie Monegro talks about the issues we can control from the onset of the trial that affect inclusiveness.